Stock Events

Seoul Pharma. 

₩3,915
2
+₩0+0% Today

Statistics

Day High
4,000
Day Low
3,800
52W High
4,745
52W Low
3,130
Volume
119,129
Avg. Volume
159,294
Mkt Cap
45B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

31DecConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-280.23
-80.14
119.96
320.06
Expected EPS
N/A
Actual EPS
-63.7121

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 018680.KQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Seoul Pharma Co., Ltd manufactures and sells pharmaceutical products in South Korea and internationally. The company offers orally disintegrating film products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer' disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V, as well as products for schizophrenia, vitamin supplement, obesity, tonic, and menopausal syndrome. The company also provides Ator for high blood pressure treatment; Flavel to treat stroke; Axated, a peptic ulcer medication; Crestin to treat hyperlipidemia; and Weltmin and Fendigene for the treatment of obesity. It also owns patents to orally dispersible films. The company was founded in 1976 and is headquartered in Cheongju-si, South Korea.
Show more...
CEO
DongHyun Yoon
Employees
230
Country
KR
ISIN
KR7018680009

Listings